Search For "gsk"
Sanofi, GSK start phase 2 trial of their COVID-19 vaccine, phase 3 could b
Updated : 4 years, 8 months ago IST
Paris [France], February 22 (ANI): Sanofi and GlaxoSmithKline (GSK) said on Monday they had begun a phase 2 trial of their COVID-19 vaccine candidates, and if results are positive, a phase 3 study could start in the second quarter of 2021.
Read More